Pages that link to "Q28335672"
Jump to navigation
Jump to search
The following pages link to Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis (Q28335672):
Displaying 50 items.
- Amino acids for amyotrophic lateral sclerosis / motor neuron disease (Q24243319) (← links)
- Amino acids for amyotrophic lateral sclerosis / motor neuron disease (Q24247715) (← links)
- The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1-22.1 in the vicinity of the gene for familial amyotrophic lateral sclerosis (Q24563838) (← links)
- Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression (Q24595928) (← links)
- Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS) (Q24613709) (← links)
- Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis (Q24630353) (← links)
- Nonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivo (Q24675057) (← links)
- Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain (Q26749567) (← links)
- Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? (Q26770781) (← links)
- Molecular motor proteins and amyotrophic lateral sclerosis (Q26820831) (← links)
- Mechanisms of glutamate transport (Q26830761) (← links)
- Glutamate transporter 1: target for the treatment of alcohol dependence (Q26861666) (← links)
- Sumoylation of critical proteins in amyotrophic lateral sclerosis: emerging pathways of pathogenesis (Q26866679) (← links)
- Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies (Q28072353) (← links)
- Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange (Q28140048) (← links)
- Glutamate uptake (Q28190140) (← links)
- From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS (Q28206361) (← links)
- Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis (Q28215132) (← links)
- Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients (Q28215473) (← links)
- Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study (Q28260466) (← links)
- Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis (Q28267385) (← links)
- Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons? (Q28273892) (← links)
- Mechanisms of neurodegeneration in amyotrophic lateral sclerosis (Q28365454) (← links)
- Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models (Q28572282) (← links)
- Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II (Q28572589) (← links)
- Synaptosomal glutamate uptake declines progressively in the spinal cord of a mutant mouse with motor neuron disease (Q28586274) (← links)
- Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability (Q30437305) (← links)
- Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons. (Q30913408) (← links)
- Biological markers in the diagnosis and treatment of ALS. (Q31389611) (← links)
- Low concentrations of glutamate induce apoptosis in cultured neurons: implications for amyotrophic lateral sclerosis (Q33185437) (← links)
- Biomarkers in amyotrophic lateral sclerosis (Q33392844) (← links)
- p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates (Q33556826) (← links)
- Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase (Q33576278) (← links)
- Human glial progenitor engraftment and gene expression is independent of the ALS environment (Q33620690) (← links)
- The role of excitotoxicity in neurodegenerative disease: implications for therapy (Q33639170) (← links)
- The Ca2+/calmodulin signaling system in the neural response to excitability. Involvement of neuronal and glial cells (Q33643179) (← links)
- Altered Metabolic Profiles Associate with Toxicity in SOD1G93A Astrocyte-Neuron Co-Cultures. (Q33671504) (← links)
- Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis (Q33675140) (← links)
- Evaluation and rehabilitation of patients with adult motor neuron disease (Q33715854) (← links)
- Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis (Q33735417) (← links)
- Molecular mechanisms regulating motor neuron development and degeneration. (Q33737440) (← links)
- Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration (Q33782744) (← links)
- AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis (Q33788455) (← links)
- Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. (Q33869419) (← links)
- Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. (Q33980768) (← links)
- D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis (Q34006224) (← links)
- BMAA--an unusual cyanobacterial neurotoxin (Q34020249) (← links)
- The endocannabinoid system as a target for the treatment of neurodegenerative disease (Q34098196) (← links)
- Mitochondrial dysfunction and intracellular calcium dysregulation in ALS (Q34103782) (← links)
- Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. (Q34182844) (← links)